Cargando…
Novel treatments and trials in COVID-19
Coronavirus disease 2019 (COVID-19), the disease arising from the beta coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented a major challenge to health-care systems and societies across the world. Although previous highly pathogenic coronaviruses have emerged, name...
Autores principales: | Conway Morris, Andrew, Tong, Allison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175765/ http://dx.doi.org/10.1016/B978-0-323-82860-4.00006-9 |
Ejemplares similares
-
GM-CSF targeting in COVID-19: an approach based on fragile foundations
por: Kohler, Katharina, et al.
Publicado: (2023) -
Post-mortem dissection of COVID-19: a pathogenic role for macrophages?
por: Velu, Prasad P., et al.
Publicado: (2021) -
Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19
por: Zaid, Younes, et al.
Publicado: (2021) -
Intensive care unit visiting and family communication during the COVID-19 pandemic: A UK survey
por: Boulton, Adam J, et al.
Publicado: (2021) -
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)
por: Ganesan, Govindaraj, et al.
Publicado: (2022)